Powered by 
Google Übersetzer
Google Übersetzer
MIAMI, FL – August 12, 2025 – Novus Acquisition and Development Corp. (OTC Markets: NDEV), a leader in providing comprehensive insurance health plans, today announced a period of financial growth and significant strategic advancements in its Provider Network. The company's performance in the first half of 2025 demonstrates a strong trajectory, underpinned by disciplined financial management and innovative market expansion.
Financial Highlights for the First Half of 2025:
Gross Revenue: The company’s gross revenue increased by 8.9% from December 31, 2024, to June 30, 2025, reflecting growing demand for its services and successful market penetration.
Net Revenue (EBITDA): In the second quarter of 2025, Novus achieved a significant 17% increase in net revenue (EBITDA) compared to the same quarter in 2024. This momentum carried through the first half of the year, with a 15% growth in net revenue (EBITDA) over the first six months of 2024.
Shareholder Equity: Shareholder equity saw a modest increase of 1.2% in the first half of the year, from December 31, 2024, to June 30, 2025, highlighting the company’s ability to generate positive value for its investors.
Cash and Cash Equivalents: The company’s financial position strengthened with a 2.53% increase in cash and cash equivalents between the reporting periods ending June 30, 2025, and June 30, 2024.
A Foundation of Financial Prudence and Shareholder Protection:
Novus has implemented a long-term strategy focused on shareholder protection and fiscal responsibility. The company has not sold any insider shares for three years, aligning the interests of management with those of its investors.1 Furthermore, Novus has no convertible notes issued or outstanding, which protects shareholders from potential dilution.
In a show of complete transparency, CEO Frank Labrozzi has disclosed a debt of $167,001 owed to him. Mr. Labrozzi has no plans to exercise the call provision, and this debt instrument does not have an equity conversion provision, ensuring that this debt will not impact shareholder value.
The company has also instituted a "leak-out" policy for vendors who have received treasury-issued stock. These vendors are contractually obligated to sell their shares gradually, based on 15% of the average daily trading volume over the past 30 days. This measure is designed to maintain market stability and prevent sudden price fluctuations.
Strategic Vision: Integrating Cannabis into Mainstream Health Plans
Novus is advancing a significant transformation in healthcare delivery by integrating cannabis-based therapies into a fully comprehensive prescription drug program. Leveraging strategic procurement agreements, the Company has secured cost reductions on nearly 25,000 generic and brand-name pharmaceuticals directly from manufacturers, enhancing both affordability and access for its policyholders. This strategic move is enabling Novus to integrate a complete prescription drug plan with cannabis into its online Rx platform. This innovative plan is designed to make cannabis-based treatments more accessible and affordable, with premiums being tax-deductible for Health Savings Accounts (HSAs).
“Novus is advancing a vision where cannabis is positioned as a core component of mainstream healthcare,” said Frank Labrozzi, CEO of Novus Acquisition & Development Corp. “By integrating cannabis into a comprehensive prescription drug plan with tax-deductible premiums, we are unlocking new avenues for market growth while delivering cost-effective, outcome-driven solutions for patients. This initiative represents a pivotal growth catalyst for the Company and positions Novus to capture significant value in a rapidly expanding sector.
Federaleral Legislation
This forward-looking strategy is bolstered by the latest comments from President Donald Trump regarding federal cannabis regulations. The President's recent remarks signaling a potential shift in federal policy and a reclassification of cannabis are a welcome and highly encouraging development. This positive momentum at the federal level supports Novus's vision and validates the company's efforts to destigmatize cannabis and establish its role in modern healthcare. The federal government's increasing openness to a more rational approach to cannabis regulation will undoubtedly accelerate Novus's growth and allow the company to provide its innovative solutions to a broader audience.
About Novus Cannabis MedPlan: Novus Cannabis MedPlan is a premier provider of medical cannabis supplemental health plans, dedicated to enhancing the accessibility and affordability of medical cannabis for patients nationwide. Through a robust network of licensed dispensaries, qualified physicians, and wellness providers, Novus delivers comprehensive membership benefits structured to support patient health journeys with transparency, dedicated care, and notable financial benefits.
Further Research:
Financial Filings: Click Here
Quote:Click Here
Investor's Page: Click Here
Forward-Looking Statements
This release includes forward-looking statements, which are based on certain assumptions and reflect management's current expectations. These forward-looking statements are subject of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, includes codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. Dilution, if any, would be for the purposes of management taking stock in lieu of cash salary. Novus disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Additionally, this press release that is a not statements of historical fact may be considered to be forward-looking statements. Written words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the near future.
Investor Contact Information
855-228-7355
Email: info@getnovusnow.com
